National Research Council Canada-Industrial Research Assistance Program (NRC-IRAP)
Development of a genomic-based diagnostic tool for prediction of diabetes complications by combining genomic and epigenomic biomarkers.
Co-investigators: Pavel Hamet and Johanne Tremblay
NRC Total Contribution 2007-2011: 400 000 $

Canadian Institute of Health Research-Circulatory and Respiratory Health : SME Industry Partnered Collaborative Research Program  
Telomere attrition rate as predictor of cardiovascular complications of type 2 diabetes.
Co-investigators: Johanne Tremblay and Pavel Hamet
CIHR Total Contribution 2010-2013: 1 400 000 $

Génome Québec
Development of a Predictive Tool for Micro & Macrovascular Complications in Patients with Type 2 Diabetes.
Principal Investigators: Pavel Hamet
Translational stream: Contribution from Génome Québec 2011-2014: 1 000 000 $